Somatostatin-receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to68Ga-DOTATATE/-TOC uptake
出版年份 2016 全文链接
标题
Somatostatin-receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to68Ga-DOTATATE/-TOC uptake
作者
关键词
-
出版物
NEURO-ONCOLOGY
Volume -, Issue -, Pages now060
出版商
Oxford University Press (OUP)
发表日期
2016-04-23
DOI
10.1093/neuonc/now060
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- 68Gallium-DOTATATE PET in meningioma: A reliable predictor of tumor growth rate?
- (2016) Michael Sommerauer et al. NEURO-ONCOLOGY
- 90Y-DOTATOC as a Therapeutic Option for Complex Recurrent or Progressive Meningiomas
- (2015) K. Gerster-Gillieron et al. JOURNAL OF NUCLEAR MEDICINE
- Increased 68Ga-DOTATATE Uptake in PET Imaging Discriminates Meningioma and Tumor-Free Tissue
- (2015) W. Rachinger et al. JOURNAL OF NUCLEAR MEDICINE
- Somatostatin Receptor-Targeted Radiopeptide Therapy with 90Y-DOTATOC and 177Lu-DOTATOC in Progressive Meningioma: Long-Term Results of a Phase II Clinical Trial
- (2015) N. Marincek et al. JOURNAL OF NUCLEAR MEDICINE
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012
- (2015) Quinn T. Ostrom et al. NEURO-ONCOLOGY
- Peptide Receptor Radionuclide Therapy in Patients with Inoperable Meningiomas: Our Experience and Review of the Literature
- (2014) Fabio Minutoli et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Recurrent high-grade meningioma: a phase II trial with somatostatin analogue therapy
- (2014) Marta Simó et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review
- (2014) T. Kaley et al. NEURO-ONCOLOGY
- Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma
- (2014) Thomas J. Kaley et al. NEURO-ONCOLOGY
- Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma
- (2014) A. D. Norden et al. NEUROLOGY
- PET SUV correlates with radionuclide uptake in peptide receptor therapy in meningioma
- (2012) Heribert Hänscheid et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Cohort Study of Somatostatin-Based Radiopeptide Therapy With [90Y-DOTA]-TOC Versus [90Y-DOTA]-TOC Plus [177Lu-DOTA]-TOC in Neuroendocrine Cancers
- (2012) Linda Villard et al. JOURNAL OF CLINICAL ONCOLOGY
- Atypical and anaplastic meningiomas treated with bevacizumab
- (2012) Lakshmi Nayak et al. JOURNAL OF NEURO-ONCOLOGY
- Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [90Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers
- (2011) Anna Imhof et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma
- (2011) David A. Reardon et al. JOURNAL OF NEURO-ONCOLOGY
- Peptide receptor radionuclide therapy with 90Y-DOTATOC in recurrent meningioma
- (2009) Mirco Bartolomei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma
- (2009) Andrew D. Norden et al. JOURNAL OF NEURO-ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation